Free Stock Tips

Hey Everybody,

Last week’s alert GRLT hit a high up 1,881% from our original alert price! Congrats to everyone still raking in profits on that one.

Speaking of profits, how about another alert with big profit potential?

We have one last alert to close out the week.

The stock has been a winner for us in the past and looks primed to make another run. Let’s get right into it.

Our alert for Friday is Nuvilex, Inc., NVLX
The stock closed Thursday at 16.4 cents

NVLX is an international biotechnology provider of live, therapeutically valuable, encapsulated cells and services for research and medicine.

There’s recent news stating, NVLX’s latest acquisition “Could Turn Out to Be Steal of the Century and Worth Billions”

NVLX’s acquisition, Bio Blue Bird AG and more importantly, its worldwide licenses associated with the live-cell encapsulation platform technology to develop treatments for all cancer types – and that’s exactly what the company got.

This news alone could not only dramatically enhance NVLX’s pipeline, but could draw a number of big name pharmaceutical and biotech companies to NVLX’s door. The key, of course, is NVLX’s future Phase III pancreatic cancer trials.

Goldman Small Cap Research recently stated NVLX is reminiscent of some of the Greatest Biotechnology Success Stories of the past 20 years including the “original biotechnology company Genetech.”

And now NVLX is planning on using the same technology to develop diabetes treatments. Bringing the company into 2 multi-billion dollar drug markets!

Look, do we know or even think that this company will be a huge success? Not sure.

But we do think this story will really excite traders and investors, and that’s all we need for a winning trade.

So make sure NVLX is on top of your watchlist Friday morning!

As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading